- Home
- DTI vs RLMD Comparison
DTI vs RLMD Comparison
Compare DTI & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTI
- RLMD
- Stock Information
- Founded
- DTI 1984
- RLMD 2004
- Country
- DTI United States
- RLMD United States
- Employees
- DTI N/A
- RLMD N/A
- Industry
- DTI Metal Fabrications
- RLMD Biotechnology: Pharmaceutical Preparations
- Sector
- DTI Industrials
- RLMD Health Care
- Exchange
- DTI Nasdaq
- RLMD Nasdaq
- Market Cap
- DTI 82.6M
- RLMD 66.7M
- IPO Year
- DTI N/A
- RLMD N/A
- Fundamental
- Price
- DTI $2.25
- RLMD $1.99
- Analyst Decision
- DTI Strong Buy
- RLMD Hold
- Analyst Count
- DTI 1
- RLMD 2
- Target Price
- DTI $5.50
- RLMD $1.00
- AVG Volume (30 Days)
- DTI 123.3K
- RLMD 517.7K
- Earning Date
- DTI 11-12-2025
- RLMD 11-06-2025
- Dividend Yield
- DTI N/A
- RLMD N/A
- EPS Growth
- DTI N/A
- RLMD N/A
- EPS
- DTI N/A
- RLMD N/A
- Revenue
- DTI $162,240,000.00
- RLMD N/A
- Revenue This Year
- DTI $0.13
- RLMD N/A
- Revenue Next Year
- DTI $1.58
- RLMD N/A
- P/E Ratio
- DTI N/A
- RLMD N/A
- Revenue Growth
- DTI 9.74
- RLMD N/A
- 52 Week Low
- DTI $1.43
- RLMD $0.24
- 52 Week High
- DTI $3.91
- RLMD $3.98
- Technical
- Relative Strength Index (RSI)
- DTI 51.75
- RLMD 59.73
- Support Level
- DTI $2.04
- RLMD $1.89
- Resistance Level
- DTI $2.49
- RLMD $2.84
- Average True Range (ATR)
- DTI 0.23
- RLMD 0.28
- MACD
- DTI 0.00
- RLMD 0.01
- Stochastic Oscillator
- DTI 56.07
- RLMD 37.96
About DTI Drilling Tools International Corporation
Drilling Tools International Corp manufactures, rents, inspects, and refurbishes downhole drilling tools primarily to companies in the oil and natural gas industry for bottom hole assemblies used in onshore and offshore horizontal and directional drilling. The company's United States operations have locations in Texas, California, Louisiana, Oklahoma, Pennsylvania, North Dakota, New Mexico, Utah, and Wyoming. The company's single segment derives revenues from customers by providing oilfield equipment and services to operators in the oil and natural gas sectors.
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.